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Objective: Maternal antenatal depression may compromise the fetal developmental milieu and contribute to individual differences in aging and
disease trajectories in later life. We evaluated the association between maternal antenatal depression and a novel biomarker of aging at birth, namely
epigenetic gestational age (GA) based on fetal cord blood methylation data. We also examined whether this biomarker prospectively predicts and
mediates maternal effects on early childhood psychiatric problems.
Method: A total of 694 mothers from the Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) Study provided
information on history of depression diagnosed before pregnancy; 581 completed the Center for Epidemiological Studies Depression Scale throughout
pregnancy, and 407 completed the Child Behavior Checklist at child’s age 3.7 years (SD ¼ 0.75 year). DNA methylation (DNAm) GA of fetal cord
blood DNA was based on the methylation profile of 148 selected cytosine linked to guanine by phosphate (CpG) sites. Epigenetic GA was calculated as
the arithmetic difference between DNAm GA and chronological GA and adjusted for chronological GA.
Results: Maternal history of depression diagnosed before pregnancy (mean difference ¼ 0.25 SD units, 95% CI ¼ 0.46 to 0.03) and greater
antenatal depressive symptoms (0.08 SD unit per 1-SD unit increase, 95% CI ¼ 0.16 to 0.004) were associated with child’s lower epigenetic GA.
Child’s lower epigenetic GA, in turn, prospectively predicted total and internalizing problems and partially mediated the effects of maternal antenatal
depression on internalizing problems in boys.
Conclusion: Maternal antenatal depression is associated with lower epigenetic GA in offspring. This lower epigenetic GA seems to be associated with a
developmental disadvantage for boys, who, in early childhood, show greater psychiatric problems.
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Depression not only hinders the health and well-being of
the pregnant mother, but is also associated with adverseperinatal and developmental outcomes in her child. The adverse outcomes
include prematurity2 and increased risks of poorer cognition and psychi-
atric problems later in life.1,3-5 Findings from these studies are compatible
with the Developmental Origins of Health and Disease (DOHaD)
framework, which suggests that in utero exposure to environmental ad-
versities may alter the structure and function of developing cells, tissues,
organs, and physiological feedback systems, leading to individual differ-
ences in aging and disease trajectories that persist throughout the lifespan.3
Mounting evidence suggests that exposure to prenatal environmental
adversity may be embedded in epigenetic alterations in the offspring, such
as in DNAmethylation (DNAm), which is characterized by the addition of
a methyl group primarily to cytosine linked to guanine by phosphate
(CpG) sites. DNAm can be used to generate aggregate markers of aging,
such as the Hannum6 and the Horvath7 epigenetic age predictors. The
Hannum age predictor is based on DNAm of 71 CpG sites in whole blood
of 19- to 101-year-old individuals,6 and the Horvath age predictor onhe American Academy of Child & Adolescent Psychiatry
/ Number 5 / May 2018DNAm of 353 CpG sites of multiple tissues of 0- to 100-year-old in-
dividuals.7 Both predictors are highly correlated with an individual’s
chronological age (r > 0.91). Having a higher DNAm age than chrono-
logical age, based on these molecular aging biomarkers, has been shown to
predict disease trajectories and mortality more accurately than chrono-
logical age.8 However, it remains less clear whether exposure to prenatal
environmental adversity is associated with epigenetic gestational age (GA)
at birth or how epigenetic GA is associated with developmental problems
later in life.
A recent study demonstrated that a higher epigenetic GA (higher
DNAm GA than chronological GA), based on the Horvath and the
Hannum epigenetic age predictors of cord blood methylation data, was
associated with maternal smoking during pregnancy and delivery by ce-
sarean section.9 These predictors are, however, not well suited for epige-
netic age estimation at birth, because their correlation with chronological
GA is nearly 0.9 A recent study generated a novel epigenetic GA biomarker
based on fetal umbilical cord blood or newborn blood spots,10 which
showed a high correlation with ultrasound-based GA.10 This study
demonstrated that lower epigenetic GA (lower DNAm GA thanwww.jaacap.org 321
SUAREZ et al.chronological GA) at birth was associated with maternal socioeconomic
disadvantage and low birth weight. We have extended these analyses by
showing that lower epigenetic GA was associated with maternal insulin-
treated gestational diabetes mellitus in a previous pregnancy and in
Sj€ogren syndrome, and higher epigenetic GA with a maternal age of more
than 40 years at delivery, neonate’s lower 1-minute Apgar score, and female
sex.11
We are unaware of any previous studies that would have tested
whether maternal antenatal depression and child psychiatric problems are
associated with child’s epigenetic GA at birth. The current study sought
to determine whether maternal history of depression diagnosed before
pregnancy and antenatal depressive symptoms were related to the child’s
epigenetic GA at birth based on fetal cord blood DNAm data. We also
tested whether these conditions exerted additive effects on child’s
epigenetic GA, as not all individuals with a history of depression diag-
nosis report high antenatal depressive symptoms and vice versa,1 and
whether the effects of antenatal depressive symptoms were gestation-stage
specific. Furthermore, we tested whether child’s epigenetic GA at birth
predicted early childhood psychiatric problems, and whether child’s
epigenetic GA mediated the associations of maternal antenatal depression
with child psychiatric problems. Finally, we tested whether the associa-
tions were moderated by child’s sex, as sex biases exist in longevity and
aging trajectories,12 epigenetic age based on the Horvath and the Han-
num epigenetic age predictors,6,9 epigenetic GA at birth,11 and preva-
lence and etiology of psychiatric problems.1,3-5,13. The effects of maternal
stress exposure during pregnancy3-5,14 and particularly antenatal depres-
sion4 on offspring developmental outcomes, have also shown sex speci-
ficity. Evidence in humans has shown that maternal antenatal depression
was associated with a higher risk of depression in the offspring at 18 years
of age, but only in girls.4 Yet, in one rodent study, maternal early
pregnancy stress was associated with a depression-like behavioral
phenotype in male but not in female offspring.14METHOD
Study Population
The Prediction and Prevention of Preeclampsia and Intrauterine Growth
Restriction (PREDO) Study comprises 1,083 pregnant women and their
singleton children born in 2006 to 2010 in Finland.15 The recruitment
took place in consecutive order when these women attended their first
ultrasound screening at 12 to 13 weeks of gestation in hospital maternity
clinics of the study. Of the recruited women, 973 had one or more risk
factors for preeclampsia and intrauterine growth restriction (IUGR), and
110 had no known risk factors.
In total, we had 814 fetal umbilical cord blood samples with full
information on genome-wide methylation and genotype passing through
quality control (see Figure S1, available online). Of this entire sample,
data on maternal depression diagnosed before pregnancy were available
for 694 individuals, on maternal antenatal depressive symptoms for 581,
and on childhood psychiatric problems at child’s mean age of 3.7 years
for 407. Table 1 describes the sample characteristics.
The Ethics Committees of the Helsinki and Uusimaa Hospital
District and the participating hospitals approved the study protocol.
Written informed consent was obtained from all participating women.Child DNA Methylation, Epigenetic, and Chronological
GA at Birth
Fetal cord blood samples were collected according to standard proced-
ures. DNA was extracted at the National Institute for Health and322 www.jaacap.orgWelfare, Helsinki, Finland, and the Institute for Molecular Medicine
Finland, University of Helsinki, Finland. Methylation analyses were
performed at the Max Planck Institute of Psychiatry in Munich, Ger-
many. DNA was bisulphite converted using the EZ-96 DNA Methyl-
ation kit (Zymo Research, Irvine, CA). Genome-wide methylation status
of more than 485,000 CpG sites was measured using the Infinium
Human Methylation 450 BeadChip (Illumina Inc., San Diego, CA)
according to the manufacturer’s protocol. The arrays were scanned using
the iScan System (Illumina Inc., San Diego, CA). The quality control
pipeline was set up using the R-package minfi.16 Samples with maternal
blood contamination were excluded (n ¼ 9) according to a method
described elsewhere.17 The final dataset contained 428,619 CpG sites.
Methylation b values were normalized according to Horvath’s
modified beta-mixture quantile (BMIQ) normalization.7
DNAm GA was calculated as described elsewhere,10 based on the
methylation profile of 148 selected CpG sites. Chronological GA was
based on ultrasound scans, and epigenetic GA was calculated as the
arithmetic difference between DNAm GA and chronological GA and
adjusted for chronological GA. Adjustment for chronological GA was
necessary to remove the effect of chronological GA entirely (Pearson
correlation between DNAm GA-GA arithmetic difference and GA
r ¼ 0.27, p < 0.01).
Child Cord Blood Cell Counts at Birth
To control for the potential effects of cell type heterogeneity in fetal
umbilical cord blood, cord blood cell counts at birth were estimated for 7
cell types (nucleated red blood cells, granulocytes, monocytes, natural
killer cells, B cells, CD4þ T cells, and CD8þ T cells) using the method
of Bakulski et al.,18 which is also incorporated in the R-package minfi.16
Child Genotyping and Multidimensional Scaling Analysis
To control for the potential effects of population structure, genotyping
was performed on Illumina Human Omni Express Exome Arrays (Illu-
mina Inc., San Diego, CA). Only markers with a call rate of at least 98%,
minor allele frequency of 1% and a p value for deviation from
HardyWeinberg equilibrium > 1  1006 were kept in the analysis.
We performed multidimensional scaling (MDS) analysis on the identity
by state matrix of quality-controlled genotypes.19 The first 2 MDS
components depicted the population structure.
Maternal History of Depression Diagnosed Before
Pregnancy and Antenatal Depressive Symptoms
Between 12þ0-13þ6 weeksþdays of gestation, the women answered the
question “Have you ever been diagnosed by a physician with depression?”
followed by a question on timing of the diagnosis. A total of 76 women
reported that the diagnosis occurred before pregnancy (3 women who did
not specify timing were excluded). Of them, 12 indicated using antide-
pressant medication during the past year. A total of 618 women reported
no history of physician-diagnosed depression and no antidepressant
medication use in the past year (3 women who reported using antide-
pressants but no depression diagnoses were excluded).
Starting from 12þ0-13þ6 weeksþdays of gestation, each woman
completed the 20 item Center for Epidemiological Studies Depression
Scale (CES-D)20 for depressive symptoms over the previous 7 days
biweekly up to 14 times until 38þ039þ6 weeksþdays of gestation or
delivery. On average, each woman filled in the CES-D 12.6 (SD ¼ 2.2)
times; of the 581 women with CES-D data, 481 (82.8%) had less than 2
missing values. We used raw data to calculate trimester-specific means ofJournal of the American Academy of Child & Adolescent Psychiatry
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TABLE 1 Sample Characteristics
Entire Sample With Fetal
Cord Blood DNA
Methylation Data (N ¼ 814)
Sample With Fetal Cord Blood DNA
Methylation and Maternal History
of Depression Diagnosed Before
Pregnancy Data (n ¼ 694)
Sample With Fetal Cord
Blood DNA Methylation and
Maternal Antenatal Depressive
Symptoms Data (n ¼ 581)
Sample With Fetal Cord Blood DNA
Methylation and Child’s Psychiatric
Problems in Early Childhood
Follow-up Data (n ¼ 407)
Mean (SD) or n (%) Range Mean (SD) or n (%) Range p1 Mean (SD) or n (%) Range p2 Mean (SD) or n (%) Range p3
Child Characteristics at Birth
Gestational age (wk) 39.8 (1.6) 31.0e42.7 39.8 (1.6) 31.0e42.7 .23 39.7 (1.6) 31.0e42.7 .48 39.8 (1.5) 31.0e42.7 .36
DNAm gestational age (wk) 38.5 (2.0) 28.5e47.1 38.5 (2.0) 29.6e47.1 .28 38.4 (2.1) 28.5e47.1 .18 38.6 (2.0) 29.6e47.1 .035
Epigenetic gestational age
(DNAm gestational age e
gestational age) (wk)
e1.3 (1.8) e10.6e7.0 e1.3 (1.8) e10.1 to 7.0 .86 e1.4 (1.9) e10.6 to 7.0 .37 e1.2 (1.9) e8.0 to 7.0 .12
Sex (boys) 430 (52.8%) 365 (52.6%) .41 299 (51.5%) .12 212 (47.9%) .36





76 (11.0%) 76 (11.0%) 1.00 62 (11.3%) .29 49 (12.9%) .11
Antenatal trimestereweighted
mean CES-D score (0e60)
11.5 (6.5) 0.7e39.9 11.5 (6.6) 0.7e39.9 .61 11.5 (6.5) 0.7e39.9 1.00 11.5 (6.7) 0.7e39.9 .86
Age over 40 years at
delivery (yes)
139 (17.1%) 119 (17.1%) .39 96 (16.5%) .35 76 (18.7%) .13
Insulin-treated gestational
diabetes mellitus in previous
pregnancy (yes)
8 (1.0%) 6 (0.9%) .13 6 (1.0%) .49 3 (0.7%) .24
Sj€ogren syndrome (yes) 11 (1.4%) 8 (1.2%) .20 9 (1.5%) .36 7 (1.7%) .28
Note: p1 Refers to p value comparing the sample with data on history of depression diagnosed before pregnancy (n ¼ 694), p2 on maternal antenatal depressive symptoms (n ¼ 581), and p3 on child’s psychiatric





















































SUAREZ et al.the CES-D sum-scores to represent the level of depressive symptoms at
each pregnancy trimester (one value at gestational weeksþdays
12þ013þ6; mean of values between 14þ027þ6 gestational
weeksþdays; mean of values between 28þ039þ6 gestational
weeksþdays). We then calculated the mean of these 3 trimester-specific
values, the trimester-weighted mean value, to represent the overall level
of antenatal depressive symptoms.Child Psychiatric Problems
When their children were 2.3 to 5.8 years old (mean 3.7, SD 0.75),
mothers completed the Child Behavior Checklist (CBCL 11/2-5) on
psychiatric problems.21 We calculated the total problems t score based on
the 99 problem items rated on a scale from 0 (not true) to 2 (very or often
true).21 We also calculated internalizing and externalizing problems t
scores, 2 subscales of the total problems.21Covariates
All analyses were adjusted for child’s chronological GA, cord blood cell
type composition and the first two MDS components. Based on our
previous findings in this cohort,11 we thereafter made adjustments for
maternal age at delivery (40 years/<40 years), insulin-treated gesta-
tional diabetes mellitus in a previous pregnancy (yes/no), Sj€ogren syn-
drome (yes/no), neonate’s 1-minute Apgar score (6/>6), and sex (girl/
boy). In the analyses of child psychiatric problems, we made further
adjustments for child’s age at follow-up (years) and maternal Beck
Depression InventoryII scores (BDI-II <14/BDI-II 14)22 reported at
the child follow-up.Statistical Analyses
We studied the associations of maternal history of depression diagnosed
before pregnancy and trimester-weighted mean of antenatal depressive
symptoms with child epigenetic GA using linear regression analysis. We
tested whether these effects were additive by adding maternal depression
diagnosis  trimester-weighted mean of antenatal depressive symptoms
interaction term into regression equation following main effects of these
variables. We examined gestation stagespecific effects with generalized
additive mixed models using a reverse temporal model23 that treated the
biweekly measures of antenatal depressive symptoms as the longitudinal
dependent variable and the child’s epigenetic GA as the time-invariant
and gestation week as the time-varying independent continuous vari-
ables; time (gestation week)  epigenetic GA interaction tested whether
the effect was gestation-stage-specific. For all these analyses, depressive
symptoms scores were square roottransformed to attain normality; the
symptom scores were further standardized to a mean of 0 and an SD of 1
to facilitate interpretation (for mixed models, the SD scores were calcu-
lated using the grand mean of the biweekly CES-D sum-scores across 12
to 39 gestational weeks and its SD to retain within-time variation).
As child’s CBCL psychiatric problems scores are not independent of
each other but, rather, represent a hierarchical structure, we first exam-
ined associations of child’s epigenetic GA with early childhood total
problems and then examined associations with child’s internalizing and
externalizing problems using linear regression analyses. Problem scores
were logarithm transformed to obtain normality and standardized to
facilitate interpretation. In our study, the 2 CBCL subscales were highly
intercorrelated (Pearson r ¼ 0.62, p < .001), and together explained
95.3% of the variance in total problems. However, to decrease the
likelihood of type 1 error, we tested the associations with the 2 subscales324 www.jaacap.orgonly if the higher level association was significant and report also
Bonferroni-corrected CIs.
In testing whether the associations varied by sex, we entered sex 
history of depression diagnosed before pregnancy/antenatal depressive
symptoms interaction term into the regression equation with child
epigenetic GA at birth as the outcome, and we entered sex  child
epigenetic GA at birth interaction into the regression equation with child
psychiatric problems as the outcome.
Finally, we tested whether child epigenetic GA at birth mediated the
association between maternal antenatal depression and child psychiatric
problems by using the PROCESS macro for SPSS (version 24.0).24
Mediation tests were conducted pending these variables were interrelated.
To validate our findings, we applied the bootstrapping method in all
analyses.We used unrestricted random samplingmethod to generate 1,000
samples, and 95% bootstrap CI (95% CI) using the normal distribution
theory; to account for type 1 error in analyses on internalizing and exter-
nalizing problems, we also used Bonferroni-corrected 95%CI (97.5%CI is
significant at 95% CI after correction for 2 tests on subscales). Statistical
analyses were performed using IBM SPSS 24.0 and SAS 9.4.
RESULTS
Table 1 shows that the subsamples with data on maternal history of
depression diagnosed before pregnancy (n ¼ 694), maternal antenatal
depressive symptoms (n ¼ 581), and child psychiatric problems
(n ¼ 407) did not differ from the entire sample in any of the studied
characteristics, except that DNAm GA was higher in the subsample with
child psychiatric problems data. Pearson correlations between DNAm
GA and GA were 0.51 (p < .001) in the entire sample, and 0.52
(p < .001), 0.50 (p < .001), and 0.47 (p < .001) in the 3 subsamples of
participants with data on maternal history of depression diagnosed before
pregnancy, data on maternal antenatal depressive symptoms, and data on
child psychiatric problems, respectively.
Maternal Antenatal Depression and Child’s Epigenetic
GA at Birth
Figure 1 shows that maternal history of depression diagnosed before
pregnancy (Figure 1A; exclusion of antidepressant users (n ¼ 12) did not
alter the finding, 95%CI0.47 to0.01) and greater antenatal depressive
symptoms (Figure 1B) were associated with lower epigenetic GA after
adjusting for child’s chronological GA, fetal cord blood cell types, and 2
MDS components (model 1). When adjusted further for the other cova-
riates (model 2), this latter association became nonsignificant (Figure 1).
Furthermore, we found that although child’s epigenetic GA was
lower for children whose mothers had a depression diagnosis, clinically
relevant antenatal depressive symptoms, or both than for children whose
mothers reported neither, the effects of maternal history of depression
diagnosed before pregnancy and antenatal depressive symptoms were not
additive (see Figure S2, available online; women with a depression
diagnosis before pregnancy had 3.61 times higher odds [95% CI ¼
2.096.27] of clinically relevant antenatal depressive symptoms
[trimester-weighted mean depressive symptoms score 16] than those
without the diagnosis).
There were no gestation stagespecific effects of antenatal depres-
sive symptoms on child’s epigenetic GA (see Figure S3, available online).
Finally, we tested whether child’s sex moderated any of the associ-
ations. There were no significant sex  maternal depression diagnosis
(95% CI ¼ 0.41 to 0.46 for interaction term) or sex  maternal
depressive symptoms (95% CI ¼ 0.07 to 0.22 for interaction term)
interactions on child’s epigenetic GA.Journal of the American Academy of Child & Adolescent Psychiatry
Volume 57 / Number 5 / May 2018
FIGURE 1 Maternal Antenatal Depression and Child’s



















































Note: (A) Means and 95% CIs of child’s epigenetic gestational age in groups
divided according to maternal history of depression diagnosed before pregnancy.
The unstandardized regression coefficients (b) and 95% CIs refer to mean differ-
ences in epigenetic gestational age between children of mothers with and without
a history of depression diagnosed before pregnancy derived from linear regres-
sion analyses. b ¼ 0.25, 95% CI ¼ 0.46 to 0.03 (model 1); b ¼ 0.24, 95%
CI ¼ 0.45 to 0.02 (model 2).
(B) Scatterplot with a regression line displaying the unstandardized regression co-
efficient (b) and 95% CIs showing associations between maternal
trimesterweighted mean antenatal depressive symptoms and child’s epigenetic
gestational age. b ¼ 0.08, 95% CI ¼ 0.16 to 0.004 (model 1); b ¼ 0.07, 95%
CI ¼ 0.15 to 0.004 (model 2).
(A and B) Regression model 1 is adjusted for child’s chronological gestational age
at birth, fetal cord blood cell type composition, and 2 multidimensional scaling
components; model 2 for model 1 plus maternal age at delivery, insulin-treated
gestational diabetes mellitus in previous pregnancy, Sj€ogren syndrome, child’s
1-minute Apgar score, and sex. Figures display Figures 1A and 1B.
EPIGENETIC CLOCK AND DEVELOPMENTChild’s Epigenetic GA at Birth and Psychiatric Problems
at 3.7 Years
Table 2 shows that there were no significant associations between child’s
epigenetic GA and psychiatric problems in the total sample. However,
sex  epigenetic GA interactions were significant for total and inter-
nalizing problems (Table 2). In model 2, there was an interaction also on
externalizing problems. The interaction between sex and epigenetic GAJournal of the American Academy of Child & Adolescent Psychiatry
Volume 57 / Number 5 / May 2018on internalizing problems remained significant after Bonferroni correc-
tion for 2 conducted tests (Bonferroni-corrected 95% CI ¼ 0.020.48
and 0.010.46 in models 1 and 2, respectively), whereas that on
externalizing problems in model 2 did not (Bonferroni-corrected 95%
CI ¼ 0.02 to 0.43).
Table 2 shows that, in boys but not in girls, lower epigenetic GA at
birth was significantly associated with greater total and internalizing
problems. In neither boys nor in girls was epigenetic GA at birth
significantly associated with externalizing problems (Table 2). Further-
more, Table S1 (available online) shows sample characteristics by sex and
highlights that, on average, boys had significantly lower epigenetic GA at
birth and higher total and externalizing problems scores than girls.Associations Between Maternal Antenatal Depression
and Child’s Psychiatric Problems at 3.7 Years: Mediation
via Child’s Epigenetic GA
The mediation analyses were conducted in boys, as epigenetic GA was
not associated with psychiatric problems in girls; and only on total and
internalizing problems, as they were predicted by child’s epigenetic GA
(Table 2) and by maternal antenatal depression in boys (see Table S2,
available online). Figure 2 shows that, in boys, epigenetic GA partially
mediated the association between antenatal depression and internalizing
problems. Mediation was not significant on total problems (95%
CI ¼ 0.001 to 0.14 for indirect effect).DISCUSSION
This study shows that maternal history of depression diagnosed before
pregnancy and higher levels of antenatal depressive symptoms were
significantly associated with child’s lower epigenetic GA at birth. The
effects of these conditions were not additive, and antenatal symptoms
effects were not gestation stage specific. This study also shows that child’s
lower epigenetic GA at birth prospectively predicted child’s total and
internalizing problems in early childhood, although only in boys. Also in
boys, child’s epigenetic GA at birth partially mediated the association of
maternal antenatal depression with child internalizing problems.
These findings may seem to contradict the findings in adult pop-
ulations that have shown that higher rather than lower epigenetic age, in
comparison to chronological age, is associated with several negative health
outcomes.8,25,26 That lower epigenetic age might indicate such an
increased risk is, however, congruent with the DOHaD concept: the risk
for aging-related diseases and mental problems is increased in individuals
exposed to prenatal environmental adversities, which are associated with
lower birth weight, lower GA, and maternal depression during preg-
nancy.1,2 Because DNA methylation has been shown to undergo
age-related changes,27 it remains possible that both lower and higher
epigenetic GA signal risk. This risk may, however, depend on life stage.
Future studies will need to evaluate this hypothesis and whether epige-
netic GA at birth predicts other epigenetic age biomarkers in later life.
Although we expected to find sex differences in the associations, it
remains elusive why the associations with psychiatric problems were
specific to boys. It has been suggested that sex differences in the “pro-
gramming effects” of prenatal stress may serve an adaptive, evolutionary
purpose. In stressful environments, it may be more adaptive for females
to be vigilant, alert, and stress responsive to protect the young; this may
become phenotypically apparent in depression and anxiety.5 For males,
aggression and stress resistance may be more adaptive as they go out,
explore new environments, and compete with other males.5 These
“adaptive” phenotypes may become vulnerabilities when they no longerwww.jaacap.org 325
TABLE 2 Associations Between Child’s Epigenetic Gestational Age at Birth and Psychiatric Problems at 3.7 Years
Psychiatric Problems in SD Units:
(Dependent Outcome Variable)




Sex  Epigenetic Gestational
Age Interactionb Boys (n ¼ 212) Girls (n ¼ 195)
ba 95% CIa 95% CIb b 95% CI b 95% CI
Total
Model 1 e0.06 e0.17 to 0.05 0.04 to 0.44 e0.16 e0.31 to e0.0003 0.08 e0.08 to 0.24
Model 2 e0.06 e0.16 to 0.05 0.06 to 0.44 e0.17 e0.32 to e0.02 0.10 e0.06 to 0.26
Internalizing
Model 1 e0.04 e0.15 to 0.08 0.05 to 0.46 e0.16 e0.31 to 0.001 0.13 e0.05 to 0.30
Model 2 e0.03 e0.15 to 0.08 0.03 to 0.43 e0.16 e0.31 to e0.01 0.14 e0.04 to 0.31
Externalizing
Model 1 e0.06 e0.17 to 0.05 e0.01 to 0.39 e0.13 e0.29 to 0.02 0.06 e0.10 to 0.23
Model 2 e0.06 e0.17 to 0.05 0.01 to 0.40 e0.15 e0.30 to 0.01 0.08 e0.08 to 0.24
Note: b refers to unstandardized regression coefficient from linear regression analysis, indicating SD change in problem scores per SD change in epigenetic gestational
age. Model 1 is adjusted for child’s chronological gestational age, fetal cord blood cell counts, 2 multidimensional scaling components from genome-wide data, child’s sex
(pooled analysis), and age at follow-up. Model 2 is adjusted for model 1 covariates plus maternal age at delivery, insulin-treated gestational diabetes mellitus in previous
pregnancy, Sj€ogren syndrome, maternal Beck Depression InventoryII score parallel to child rating, and child’s 1-minute Apgar score.
aMain effects in the total sample are tested without sex  epigenetic gestational age interaction term, whereas sex  epigenetic gestational age interactions are tested in
the presence of main effects of these predictor variables.
bThese CIs pertain to the interaction term “sex  epigenetic gestational age” tested in the presence of main effects.
SUAREZ et al.match the environments.14 The association that we found with the
internalizing phenotype in boys contradicts the suggested evolutionarily
adaptive male phenotype. It also contradicts previous findings showing
that maternal depression during pregnancy predicts depression specif-








Note: Mediation analyses showing that maternal antenatal depression (history of depres
child’s epigenetic gestational age at birth to have an impact on child’s internalizing prob
and 95% CIs. The associations are adjusted for child’s chronological GA at birth, fetal co
age at delivery, insulin-treated gestational diabetes mellitus in previous pregnancy, Sj€og
1-minute Apgar score, and age at early childhood testing.
326 www.jaacap.orgeffects of antenatal depression on offspring psychopathology in both
sexes,3,5 and, corresponding with our findings, a rodent study showed
that maternal early pregnancy stress predicted a depression-like pheno-
type only in male offspring.14 Indeed, evidence exists suggesting that
what might be phenotypically adaptive for males and females may beEpigenetic Gestational Age at Birth on Child’s Psychiatric
Child’s Internalizing problems 
at age 3.7 years  
c gestaonal  
 birth
4, 95% CI 0.001;0.15











sion diagnosed before pregnancy or antenatal depressive symptoms) act partly via
lems among boys. The numbers represent standardized regression coefficients (b)
rd blood cell type composition, 2 multidimensional scaling components, maternal
ren syndrome, Beck Depression InventoryII scores parallel to child ratings, child’s
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EPIGENETIC CLOCK AND DEVELOPMENTdetermined by a complex interaction of type, timing, severity, and
chronicity of the prenatal stress exposure and the developmental stage of
the offspring.5,14 Whether lower epigenetic GA in boys would also
predict other outcomes or would become predictive of outcomes in girls
in later life stages is the subject of ongoing studies. Furthermore, since we
found that boys had lower epigenetic GA at birth and higher total and
externalizing psychiatric problems in early childhood than girls, the sex
differences in the associations of epigenetic GA and psychiatric problems
may also possibly have resulted from a greater ability to detect such as-
sociations in boys. Yet, we found no sex differences in the levels of
internalizing problems, but epigenetic GA and internalizing problems
were also associated only in boys. The findings on the possible sex
specificity of the effects of prenatal stress on offspring developmental
outcomes are inconclusive, and a consensus exists that further exploration
of the potential sex specificity of prenatal programming effects is
needed.5,14
The main study strength pertains to the well-characterized, ethni-
cally homogenous cohort and prospective motherchild data. Chrono-
logical GA was based on ultrasound scans, and we applied novel
bioinformatics methods to account for any sample contamination by
maternal blood17 and for the effects of cell type heterogeneity18 and
genetic population structure,19 which are factors strongly influencing
epigenetic profiles.28 Furthermore, we validated our findings by using the
bootstrap method and applied a hierarchically structured analysis strategy
when we examined child psychiatric problems to decrease the likelihood
of false-positive findings. We also corrected these analyses for multiple
testing, and the sex interaction on internalizing problems remained sig-
nificant. Yet, our novel findings must be interpreted with caution, and
further studies are needed to confirm or refute them.
The limitations of our study relate to our recruitment strategy,
which was based on women’s risk factor status for preeclampsia and
IUGR, the ethnic homogeneity of our sample, and the use of one tissue
type, precluding generalizations to groups that differ from ours and other
tissues. Sample attrition limits the generalizability of our study findings,
and the low number of mothers with depression diagnosis limited our
statistical power to assess additive effects of depression before and during
pregnancy. Also, the biological mechanisms driving the effects found
remain unclear. During pregnancy, these mechanisms may include
depression-related endocrine factors, neurotransmitters, and levels of
inflammatory markers in the mother, fetus, and placenta.29 In fact,
epigenetic age acceleration in adults may be driven by direct effects of
glucocorticoids on DNA methylation.30 The mechanisms involved after
birth may include structural and functional immaturity of organs and
problems in neonatal adaptation increasing vulnerability toJournal of the American Academy of Child & Adolescent Psychiatry
Volume 57 / Number 5 / May 2018developmental adversities. Maternal depression after pregnancy may also
compromise the developing attachment bond. However, in our study,
maternal depression parallel to rating the child did not account for the
associations found between child epigenetic GA at birth and child psy-
chiatric problems.
In summary, children of mothers with a history of depression
diagnosed before pregnancy or with greater antenatal depressive
symptoms display lower epigenetic GA at birth. This lower epigenetic
GA at birth seems to be associated with a developmental disadvantage
for boys, who went on to display greater psychiatric problems in early
childhood. Lower epigenetic GA actually partially mediated the effects
of maternal depression on child outcome. Epigenetic GA at birth may
hold potential for identifying, before the onset of psychiatric problems,
at-risk children, thereby allowing for timely, personalized preventive
interventions.Accepted March 9, 2018.
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FIGURE S1 Flow Chart of the Prediction and Prevention of Preeclampsia and Intrauterine Growth Retardation (PREDO) Study
and Sample Attrition
876 fetal cord blood DNA samples
available for genome-wide methylaon analysis 
using Infinium Human Methylaon 450 BeadChip
3 samples excluded: 
missing chronological gestaonal age data and 
an outlier with epigenec gestaonal age
>5 SD 
694 with data on maternal history of depression diagnosed before pregnancy 
581 with data on maternal antenatal depressive symptoms 
407 with data on child psychiatric problems in early childhood follow-up
817 fetal cord blood DNA samples
valid informaon on genome-wide methylaon and 
genotype data
814 fetal cord blood DNA samples
with child epigenec gestaonal age
825 fetal cord blood DNA samples
passed quality control procedures and 
had full informaon on genome-wide methylaon 8 samples excluded: 
call rate below 98% and discrepancies between 
phenotypic and genotypic sex in 
genome-wide genotype data
42 samples excluded: 
duplicates, outliers in the median intensies, cross-
hybridizing probes or probes containing SNPs and 
CpG sites with a detecon P-value > 0.01 in at least 
50% of the samples, due to locaon on chromosome
         X or Y, orsex discrepancies   834 fetal cord blood DNA samples
full informaon on genome-wide methylaon and 
DNAm gestaonal age was calculated
9 samples excluded: 
maternal blood contaminaon
EPIGENETIC CLOCK AND DEVELOPMENTTABLE S1 Characteristics of the Sample With Data on Child Psychiatric Problems in Early Childhood Follow-up Stratified by
Child’s Sex (n ¼ 407)
Characteristics
Boys (n ¼ 212) Girls (n ¼ 195)
p Boys vs. GirlsMean (SD) or n (%) Range Mean (SD) or n (%) Range
Child Characteristics at Birth and in Early Childhood
Gestational age (wk) 39.8 (1.5) 34.4e42.7 39.9 (1.5) 31.0e42.0 .74
DNAm gestational age (wk) 38.3 (2.0) 32.8e45.8 38.9 (2.0) 29.6e47.1 .003
Epigenetic gestational age (DNAm gestational age e
gestational age) (wk)
e1.5 (2.0) e7.1 to 7.0 e0.9 (1.7) e8.0 to 6.8 .003
Age at follow-up (y) 3.7 (0.8) 2.4e5.8 3.6 (0.8) 2.3e5.8 .63
1-min Apgar score 6 (yes) 12 (5.7%) 10 (5.1%) .49
Psychiatric problems
Total 46.6 (9.6) 28.0e74.0 44.4 (7.9) 28.0e68.0 .010
Internalizing 45.3 (9.0) 29.0e76.0 44.6 (8.4) 29.0e70.0 .43
Externalizing 48.4 (9.5) 28.0e83.0 45.3 (7.8) 28.0e67.0 <.001
Maternal Characteristics
History of depression diagnosed before pregnancy (yes) 31 (15.5%) 18 (9.9%) .071
Antenatal trimesterLweighted mean score of
CES-D (0L60)
11.7 (6.7) 1.0e39.8 11.2 (6.7) 0.7e35.3 .49
Age >40 y at delivery (yes) 42 (19.8%) 34 (17.4%) .31
Insulin-treated gestational diabetes mellitus in previous
pregnancy (yes)
2 (0.9%) 1 (0.5%) .53
Sj€ogren syndrome (yes) 5 (2.4%) 2 (1.0%) .26
BDI-II score in early childhood follow-up 6.8 (7.1) 0.0e41.0 6.3 (6.1) 0.0e30.0 .39
Note: BDI-II ¼ Beck Depression InventoryII; CES-D ¼ Center for Epidemiological Studies Depression Scale; DNAm ¼ DNA methylation.
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TABLE S2 Associations Between Maternal Antenatal Depression (History of Depression Diagnosed Before Pregnancy or Center
for Epidemiological Studies Depression Scale Score 16 vs. Neither One) and Child’s Psychiatric Problems at 3.7 Years
Child’s Psychiatric Problems
Boys (n ¼ 212) Girls (n ¼ 195)
Mean Difference: Yes vs.
No Maternal
Antenatal Depression 95% CI
Mean Difference: Yes vs.
No Maternal
Antenatal Depression 95% CI
Total 0.51 0.21e0.81 0.49 0.20e0.78
Internalizing 0.46 0.16e0.76 0.48 0.17e0.80
Note: Model adjusted for child’s age at testing.
FIGURE S3 Associations Between Maternal Antenatal
Depressive Symptoms at Different Stages of Pregnancy and
Child’s Epigenetic Gestational Age
Note: To test whether the associations were gestation stage specific, we used
generalized additive mixed models (reverse temporal model) that treated the
biweekly measures of antenatal depressive symptoms as the longitudinal depen-
dent variable and epigenetic gestational age as the time-invariant continuous var-
iable and gestation week as the time-varying independent continuous variable;
time (gestation week)  epigenetic gestational age interaction tested whether
the effect on biweekly antenatal depressive symptoms was gestation stage spe-
cific. For display purposes, regression lines are presented pooling the individual
slopes for the first trimester (slopes at 12þ013þ6 weeks of gestation), second
trimester (mean of slopes between 14þ027þ6 gestational weeks), and third
trimester (mean of slopes between 28þ039þ6 gestational weeks).
FIGURE S2 Lack of Additive Effects of Maternal History of
Depression Diagnosed Before Pregnancy and Antenatal
TrimesterWeighted Mean Center for Epidemiological
Studies Depression Scale (CES-D) Score on Child’s








































Note: 95% ¼ 0.31 to 0.61 (model 1), 95% CI ¼ 0.32 to 0.60 (model 2) for
maternal history of depression diagnosed before pregnancy (yes versus no) 
antenatal trimesterweighted mean Center for Epidemiological Studies Depres-
sion Scale (CES-D) score (CES-D 16 versus <16) interaction; mean
difference ¼ 0.18, 95% CI ¼ 0.34 to 0.03 (model 1), 95% CI ¼ 0.33
to 0.02 (model 2) for no diagnosis and CES-D <16 versus other groups. A total
of 37 women who had antenatal depressive symptoms data did not have data
on history of depression diagnosed before pregnancy. Model 1 is adjusted for
child’s chronological GA at birth, fetal cord blood cell type composition, and 2
multidimensional scaling components; and Model 2 for Model 1 covariates plus
maternal age at delivery, insulin-treated gestational diabetes mellitus in previous
pregnancy, Sj€ogren syndrome, child’s 1-minute Apgar score, and sex.
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